CTOs on the Move


 
mbcmw is a Northbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mbcmw.com
  • 3400 Dundee Rd Ste 200
    Northbrook, IL USA 60062
  • Phone: 847.498.8880

Executives

Name Title Contact Details

Similar Companies

TransMedics

TransMedics Inc. is the world`s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. The company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. The OCS Lung, OCS Heart and OCS Liver are all CE marked and FDA approved devices.

Graham Field Health Products

GF Health Products, headquartered in Atlanta, Ga., is a major manufacturer and distributor of healthcare products for homecare, long-term care, primary care and acute care markets. Its products include medical/surgical products, diagnostics, patient room

Venclose

We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.